Atrial Fibrillation

Atrial fibrillation (AF) is the most prevalent type of persistent arrhythmia worldwide, with over 20 million patients in China. The incidence of AF is continuously increasing along with the aging of the population, significantly increasing the risks of stroke, heart failure, and all-cause mortality, and imposing a heavy burden on healthcare and society…….

Ventricular Arrhythmias

Mapping technology is an important tool for ventricular arrhythmia research. Relying on optical mapping and other equipment, it can accurately capture the changes in myocardial electrophysiology and calcium signals, providing scientific and intuitive experimental data support for exploring the pathogenesis of arrhythmias, evaluating drug effects and…….

Myocardial Infarction

Atrial fibrillation (AF) Myocardial infarction (MI) is a severe cardiovascular disease caused by the sudden reduction or interruption of coronary blood supply, characterized by myocardial ischemia, hypoxia and necrosis. It readily triggers fatal complications such as arrhythmia, shock and heart failure, and is followed by myocardial fibrosis and…….

Cardiac Tissue Engineering

In cardiac tissue engineering, restoring electrical function is as vital as structural repair. Electrophysiological mapping has become the gold standard for evaluating how engineered constructs integrate with host myocardium. Using high-density multielectrode arrays, MappingLab systems enable precise quantification of conduction velocit…….

Drug evaluation and screening

Cardiovascular diseases remain a major fatal challenge to global health, creating an urgent clinical demand for innovative drugs that are safe, effective, and adaptable to diverse therapeutic needs. Current Western and traditional Chinese medicines each offer distinct advantages in the prevention and treatment of cardiovascular diseases…….

Regenerative Medicine

Induced Pluripotent Stem Cell (iPSC) reprogramming and organoid systems are transformative pillars of global regenerative medicine, addressing critical unmet healthcare needs including organ donor shortages, limited disease mechanistic insights, and low novel drug development success rates. With breakthroughs across cardiovascular, neurological, oncological and…….